MRI引导放疗系统在线自适应胰腺癌治疗计划的剂量学质量
该研究对74次在线自适应胰腺癌放疗中的30次进行回顾性重新计划,以评估在线自适应计划是否因时间限制而剂量学欠优。结果显示7次重新计划获得至少5%的PTV覆盖改善(平均增加11%),OAR保护无临床显著改善;
要点
- 至少10%的SMART分次可通过更充分的重新计划改善剂量学质量。
- 7/30次重新计划PTV覆盖改善≥5%,平均增加11%。
- OAR保护无临床显著改善,射束开启时间变化无相关性。
核心结论
- 至少10%的SMART分次的剂量学计划质量可通过比当前在线执行的更广泛的重新计划来改善。
研究设计与样本
- 对74次连续自适应分次中30次因PTV/GTV覆盖不足或OAR剂量超过理想约束而进行回顾性重新计划。
- 重新计划通过迭代调整剂量-体积目标直至优化,目标为改善PTV/GTV覆盖同时保持或降低胃肠道OAR剂量,或降低OAR剂量同时保持或提高PTV覆盖。
- 全局最大剂量要求维持在治疗自适应计划的2%以内,以消除混杂因素。
- 临床显著改善定义为PTV覆盖提高5%或OAR剂量降低5%。
主要发现
- 30次重新计划中7次获得至少5%的PTV覆盖改善,这些计划的PTV覆盖平均增加11%。
- 没有计划在OAR保护方面获得临床显著改善。
- 射束开启时间的变化未显示任何相关性。
关键数值与推荐
- 临床显著改善阈值:PTV覆盖提高5%或OAR剂量降低5%。
- 全局最大剂量需维持在治疗自适应计划的2%以内。
临床怎么用
- 在线自适应胰腺癌放疗中,部分计划可通过更深入的重新计划改善靶区覆盖。
- 需要开发自动化重新计划工作流程,以将深度重新计划融入在线自适应工作流程。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic magnetic resonance image-guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may result in dosimetrically suboptimal plans. The purpose of this study was to quantitatively address that question through systemic retrospective replanning of treated on-table adaptive pancreatic cancer cases. METHODS AND MATERIALS: Of 74 consecutive adapted fractions, 30 were retrospectively replanned based on deficiencies in planning target volume (PTV) and gross tumor volume (GTV) coverage or doses to organs-at-risk (OARs) that exceeded ideal constraints. Retrospective plans were created by adjusting dose-volume objectives in an iterative fashion until deemed optimized. The goal of replanning was to improve PTV/GTV coverage while keeping the dose to gastrointestinal OARs the same or lower or to reduce OAR doses while keeping PTV coverage the same or higher. The global maximum dose was required to be maintained within 2% of that of the treated adaptive plan to eliminate it as a confounding factor. A threshold of 5% improvement in PTV coverage or 5% decrease in OAR dose was used to define a clinically significant improvement. RESULTS: Of the 30 replans, 7 obtained at least 5% PTV coverage improvement. The average increase in PTV coverage for these plans was 11%. No plans were clinically significantly improved in terms of OAR sparing. Changes in beam-on time did not show any correlation. Statistical analysis via a linear mixed-effects model with a nested random effect suggested that both GTV and PTV coverage were improved over SMART process plans by 0.91 cc (P = .02) and 2.03 cc (P < .001), respectively. CONCLUSIONS: Dosimetric plan quality of at least 10% of SMART fractions may be improved through more extensive replanning than is currently performed on-table. Further work is needed to develop an automated replanning workflow to streamline the in-depth replanning process to better fit into an on-table adaptive workflow.
引用
- Chow PE, Chu FI, Agazaryan N, et al. Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System. Adv Radiat Oncol. 2021. PMID: 33898868. doi:10.1016/j.adro.2021.100682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。